Listing, J <br/><br/>
Impact of anti-tumour necrosis factor alpha treatment on admissions to hospital and days of sick leave in patients with ankylosing spondylitis.  [electronic resource] 

 -  Annals of the rheumatic diseases  Dec 2004 
 - 1670-2 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0003-4967 
<br/><br/><label>Standard No.: </label>10.1136/ard.2003.017327  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antirheumatic Agents--therapeutic use<br/>Cost of Illness<br/>Double-Blind Method<br/>Female<br/>Follow-Up Studies<br/>Germany<br/>Hospitalization--statistics & numerical data<br/>Humans<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Sick Leave--statistics & numerical data<br/>Spondylitis, Ankylosing--drug therapy<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors